Form 990 for tax year 2022
Filed by LMSARCOMA DIRECT RESEARCH FOUNDATION.
Totals
- Total revenue
- $374,295
- Total expenses
- $225,656
- Contributions and grants received
- $368,755
- Grants paid
- $213,390
- Program service revenue
- $0
- Investment income
- $5,300
- Other revenue
- $240
- Total assets, end of year
- $715,769
- Total liabilities, end of year
- $1,832
- Net assets or fund balances, end of year
- $713,937
- Program services expenses (Part IX)
- $219,126
- Management and general expenses
- $3,404
- Fundraising expenses
- $3,126
- Program service expenses (Part III)
- $219,126
Program services were 97.1% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1a · Federated campaigns
$0
-
1b · Membership dues
$0
-
1c · Fundraising events
$0
-
1d · Related organizations
$0
-
1e · Government grants (contributions)
$0
-
1f · All other contributions, gifts and grants
$368,755
-
1g · Noncash contributions included above
$0
-
3 · Investment income
total $5,300 · related or exempt $5,300 · unrelated business $0 · excluded $0
-
4 · Income from investment of tax-exempt bond proceeds
total $0 · related or exempt $0 · unrelated business $0 · excluded $0
-
5 · Royalties
total $240 · related or exempt $240 · unrelated business $0 · excluded $0
-
6c · Rental income or loss
real property $0 · personal property $0
-
7c · Gain or loss
securities $0 · other assets $0
-
8a · Fundraising events: contributions included on line 1c
$0
-
11e · Other revenue, total
$0
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $213,390 · program services $213,390
-
2 · Grants to domestic individuals
total $0 · program services $0
-
3 · Grants to foreign organizations and individuals
total $0 · program services $0
-
4 · Benefits paid to or for members
total $0 · program services $0
-
5 · Compensation of officers, directors and key employees
total $0 · program services $0 · management and general $0 · fundraising $0
-
6 · Compensation of disqualified persons
total $0 · program services $0 · management and general $0 · fundraising $0
-
7 · Other salaries and wages
total $0 · program services $0 · management and general $0 · fundraising $0
-
8 · Pension plan contributions
total $0 · program services $0 · management and general $0 · fundraising $0
-
9 · Other employee benefits
total $0 · program services $0 · management and general $0 · fundraising $0
-
10 · Payroll taxes
total $0 · program services $0 · management and general $0 · fundraising $0
-
11c · Fees: accounting
total $2,400 · management and general $2,400
-
13 · Office expenses
total $1,004 · management and general $1,004
-
14 · Information technology
total $5,736 · program services $5,736
-
24a · Other expenses: Payment Processing Fees
total $3,126 · program services $0 · management and general $0 · fundraising $3,126
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $147,450 · end of year $114,226
-
2 · Savings and temporary cash investments
beginning of year $419,680 · end of year $601,543
-
17 · Accounts payable and accrued expenses
beginning of year $1,832 · end of year $1,832
-
29 · Capital stock, trust principal or current funds
beginning of year $0 · end of year $0
-
30 · Paid-in or capital surplus, or land, building or equipment fund
beginning of year $0 · end of year $0
-
31 · Retained earnings, endowment or other funds
beginning of year $565,298 · end of year $713,937
Mission and programs · 2022
Mission
To help find a cure for leiomyosarcoma by creating relationships with researchers and funding research that can lead to an effective treatment. To provide a forum for patients and care givers to share there experiences and to keep them informed of current studies.
Activities or mission (Part I)
To help find a cure for Leiomyosarcoma by creating a relationship with researchers in which we help fund projects that can lead to effective treatments. The secondary mission is to provide a forum for Patients and care givers to share information and access to the latest studies.
-
Withheld by Nonprofiteer: this text may name a private individual.
Expenses $50,000 · Grants $50,000 · Revenue $50,000
-
We established a Support Group Lifeline in order to serve newly diagnosed patients with information, support, guidance, and hope for treatment of their condition.
-
We funded 5 additional cancer research grants to accelerate the knowledge toward treatment for Leiomyosarcoma.
Expenses $163,390 · Grants $163,390 · Revenue $163,390
-
Provided an online web page and Facebook Group for Patient support and information sharing.
Expenses $5,736 · Revenue $5,736
As filed on the 2022 return. A text marked withheld matched a screen for wording that may name a private individual, such as an honorific or "in memory of". Most of what it withholds names no one; it is withheld so that what does is never shown.
Listed in Part VII
-
Howard Smith
Dir
- Total calculated
- $0
- Hours/week
- 1
-
Sharon Anderson
President
- Total calculated
- $0
- Hours/week
- 10
-
Edward Kurtz
Treasurer and V. President
- Total calculated
- $0
- Hours/week
- 2
-
Denice Brice
Secretary
- Total calculated
- $0
- Hours/week
- 2
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
-
$50,000
Ongoing LMS research conducted by Dr. William Tseng.
-
Sarcoma Alliance for Research Collaboration
$50,000
Cancer research
-
$50,000
Cancer research.
-
$38,635
Cancer research
-
Tatiana Omelchenko
$19,138
Cancer research.
-
The Rockefeller University
$5,618
Cancer research.
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 6 November 2023
- IRS schema version
- 2022v5.0
- Source object
- 202303119349302860
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.